ArticleBMC biology2025
Juvenile hormone and BMP signaling modulate fat body cell fate during the transition of previtellogenic development to vitellogenesis.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundInsect fat body, a central tissue for nutrient storage, energy metabolism, and protein synthesis, degrades by apoptosis and autophagy during larval metamorphosis. After adult emergence, the fat body grows rapidly with cell proliferation and polyploidization during the previtellogenic period but ceases cell proliferation in the vitellogenic phase. So far, the regulatory mechanisms underlying fat body cell fate decisions in adulthood remain unknown.
resultsTranscriptomic analysis of locust fat body revealed the enrichment of pathways associated with cell cycle, nuclear division, and DNA replication. Decapentaplegic (Dpp) was among the top of differentially expressed genes in the signaling cascades involved in regulating cell proliferation. Abundance of Dpp, phosphorylated Mad (p-Mad), and Medea increased during the previtellogenic stage and subsequently declined in the vitellogenic phase. Knockdown of Dpp, Mad, and Medea resulted in suppressed fat body cell proliferation, along with remarkably reduced cell number and blocked vitellogenin (Vg) expression in the fat body as well as consequent arrest of egg development. Mad/Medea complex bound to the promoters of cyclin B (CycB) and polo-like kinase 1 (Plk1) and stimulated their expression. Depletion of CycB and Plk1 caused the defective phenotypes resembling Dpp, Mad, and Medea knockdown. In the vitellogenic phase, the high levels of juvenile hormone (JH) promoted the degradation of Medea via fizzy-related protein (Fzr)-mediated ubiquitination, leading to inhibited cell proliferation. The results suggest that fat body cell proliferation in the previtellogenic development is promoted by the bone morphogenetic protein (BMP) signaling pathway, whereas high levels of JH in the vitellogenic stage antagonize BMP signaling for ceasing cell proliferation.
conclusionsThe findings provide novel insights into the regulation of fat body cell fate during the transition of previtellogenic growth to vitellogenic Vg synthesis for reproductive requirements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.